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Background
In a recent randomized double-blind sham-controlled
study the Cefaly®, a novel transcutaneous supraorbital
electrostimulation device, has been successfully used as
a prophylactic treatment for episodic migraine. The pos-
sible mechanisms of action through which the device is
able to induce clinical improvement in migraine are not
known. In the present study, we investigated whether
Cefaly® may act centrally at the thalamocortical/cortical
level.
Methods
To explore the central mechanisms of action of Cefaly®,
we recorded the somatosensory evoked potentials (SSEPs)
before, and in the subsequent two times after one session
of supraorbital stimulation lasting 20 min in 10 migraine
without aura patients between attacks. We measured the
N20-P25 amplitudes on the low-frequency-SSEP, and,
after applying a band-pass filter (450-750 Hz), maximal
peak-to-peak amplitudes of the pre-synaptic, reflecting
thalamocortical activity, and post-synaptic, reflecting pri-
mary cortical activation, high-frequency oscillations
(HFOs).
Results
Pre-synaptic HFO amplitudes, reflecting somatosensory
thalamocortical activity, significantly increased after the
stimulation (from 0.035 V to 0.058 V, p < 0.01), whereas
both the low-frequency N20 SSEP component and post-
synaptic HFOs were unaffected.
Conclusions
Present data might support the hypothesis that Cefaly®
acts centrally through increased thalamocortical activity
induced by the neurostimulation. It is of obvious interest
to verify whether these device-induced changes might
persist in the long-term after 3-month daily preventive
stimulation, and if they follow clinical improvement.
Written informed consent to publish was obtained
from the patient(s).
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